The efficacy of increasing doses of MDM2 inhibitor SAR405838 on our liposarcoma cell lines was already reported (Bill et al., 2016; Tahara et al., 2023), the aim of this assessment was to investigate how our Collagen 3D models were affected by the drug treatment. This evidence concerns the gene MDM2 and liposarcoma.